Trovafloxacin is active against Toxoplasma gondii.
Drugs currently used for treatment of toxoplasmosis in pregnant women, congenital infections, immunocompromised patients, and patients with the ocular disease are not always effective or may be dangerous to use; therefore, there is a need for more-effective and less-toxic drugs. Recently, we examine...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1996
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163429/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8843293/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.8.1855 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|